NCT01184885 2025-05-04
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
Clinical Trials
1 trialsPhase EARLY_PHASE1 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Cyclophosphamide × Clear all